Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Will spinach reheat NUFA?

This article was originally published in The Tan Sheet

Executive Summary

Consumers Union cites the recent contamination of fresh spinach with E. coli bacteria as a reason to oppose passage of the National Uniformity for Food Act (S 3128). The bill, which would unify warning label requirements and preempt state-imposed requirements like California's Prop 65, passed the House in February with an amendment exempting warnings related to dietary supplements. No action has been taken on NUFA since a July Senate Health, Education, Labor & Pensions Committee hearing, and Consumers Union does not think the bill will be taken up during the lame-duck session. Congress "is not really doing much of a substantive nature between now and the new session," a spokesperson said (1"The Tan Sheet" July 31, 2006, In Brief). However, the group expects NUFA will be reintroduced into the new Congress and notes Speaker-designate Rep. Nancy Pelosi (D-Calif.) opposes the bill. Supplement trade groups have not heard rumblings on the Hill about new movement on the bill in light of the spinach contamination...

You may also be interested in...



NUFA hearing

The Senate Committee on Health, Education, Labor & Pensions held a hearing on the National Uniformity for Food Act (S 3128) July 27. Witnesses included Peter Barton Hutt, Senior Counsel for Covington & Burling (Washington, D.C.), and former FDA Associate Commissioner for Policy William Hubbard. The HELP committee does not expect to vote on the legislation until after the August recess. NUFA was introduced in the House in October 2005. After the bill (H.R. 4167) passed the House in late February, it was referred to the Senate. The companion bill was introduced by Sen. Richard Burr (R-N.C.) May 25...

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.

Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups

Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100015

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel